Citadel Advisors’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$605K Buy
194,653
+124,044
+176% +$386K ﹤0.01% 3843
2025
Q1
$239K Buy
70,609
+67,051
+1,885% +$227K ﹤0.01% 4715
2024
Q4
$20.2K Sell
3,558
-244,078
-99% -$1.38M ﹤0.01% 5646
2024
Q3
$1.45M Buy
247,636
+132,047
+114% +$772K ﹤0.01% 2777
2024
Q2
$914K Buy
115,589
+89,063
+336% +$704K ﹤0.01% 3140
2024
Q1
$247K Buy
+26,526
New +$247K ﹤0.01% 4590
2023
Q4
Sell
-28,885
Closed -$224K 6741
2023
Q3
$224K Sell
28,885
-191,910
-87% -$1.49M ﹤0.01% 4471
2023
Q2
$2.53M Buy
220,795
+117,282
+113% +$1.34M ﹤0.01% 2243
2023
Q1
$798K Sell
103,513
-58,404
-36% -$450K ﹤0.01% 3408
2022
Q4
$988K Sell
161,917
-60,540
-27% -$369K ﹤0.01% 3215
2022
Q3
$1.32M Buy
222,457
+139,637
+169% +$827K ﹤0.01% 3141
2022
Q2
$490K Sell
82,820
-57,173
-41% -$338K ﹤0.01% 4166
2022
Q1
$1.07M Buy
139,993
+71,702
+105% +$546K ﹤0.01% 3671
2021
Q4
$185K Sell
68,291
-914,533
-93% -$2.48M ﹤0.01% 5530
2021
Q3
$2.59M Sell
982,824
-623,670
-39% -$1.64M ﹤0.01% 2723
2021
Q2
$6.64M Buy
1,606,494
+1,363,816
+562% +$5.63M ﹤0.01% 1841
2021
Q1
$1.14M Sell
242,678
-591,274
-71% -$2.78M ﹤0.01% 3790
2020
Q4
$5.96M Sell
833,952
-4,926
-0.6% -$35.2K ﹤0.01% 1626
2020
Q3
$8.95M Buy
838,878
+314,120
+60% +$3.35M ﹤0.01% 1166
2020
Q2
$6.62M Buy
524,758
+408,507
+351% +$5.16M ﹤0.01% 1331
2020
Q1
$1.06M Sell
116,251
-382,157
-77% -$3.49M ﹤0.01% 2806
2019
Q4
$6.95M Buy
498,408
+100,161
+25% +$1.4M ﹤0.01% 1405
2019
Q3
$6.85M Buy
398,247
+255,536
+179% +$4.4M ﹤0.01% 1446
2019
Q2
$3.89M Buy
+142,711
New +$3.89M ﹤0.01% 1851
2019
Q1
Sell
-31,619
Closed -$297K 5078
2018
Q4
$297K Sell
31,619
-20,691
-40% -$194K ﹤0.01% 3616
2018
Q3
$990K Buy
+52,310
New +$990K ﹤0.01% 2728
2018
Q2
Sell
-76,603
Closed -$1.44M 4625
2018
Q1
$1.44M Sell
76,603
-19,334
-20% -$363K ﹤0.01% 2178
2017
Q4
$1.59M Sell
95,937
-154,447
-62% -$2.56M ﹤0.01% 2061
2017
Q3
$5.16M Buy
+250,384
New +$5.16M ﹤0.01% 1255